BRIAN JONES: Open Payments
NPI 1982218848 · FINDLAY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 11 payments from 5 companies in 2025. Trend: 2023 $13 · 2024 $0 · 2025 $255
Food & beverage: $255
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $96 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| Celgene Corporation | 2 | $39 |
| PFIZER INC. | 2 | $37 |
| Gilead Sciences, Inc. | 1 | $24 |
Products named: IMBRUVICA, LUTATHERA, REBLOZYL, IBRANCE, EPKINLY, Trodelvy.
Industry payments across OH — which companies pay providers there.
